ResMed Share Based Compensation Trend

RMD -- USA Stock  

USD 115.68  1.74  1.53%

This module enables investors to look at ResMed various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 414.6 M, Cost of Revenue of 908.5 M or Earning Before Interest and Taxes EBIT of 530.3 M, but also many exotic indicators such as Long Term Debt to Equity of 0.6074, Calculated Tax Rate of 23.327 or PPandE Turnover of 5.5886. This module is a perfect complement to use when analyzing ResMed Valuation or Volatility. It can also complement various ResMed Technical models. Additionally take a look at analysis of ResMed Correlation with competitors.
Showing smoothed Share Based Compensation of ResMed with missing and latest data points interpolated. A component of Net Cash Flow from Operations representing the total amount of noncash; equity-based employee remuneration. This may include the value of stock or unit options; amortization of restricted stock or units; and adjustment for officers' compensation. As noncash; this element is an add back when calculating net cash generated by operating activities using the indirect method.
Share Based Compensation10 Years Trend
Increasing
Slightly volatile
 Share Based Compensation 
      Timeline 

ResMed Regression Statistics

Arithmetic Mean 28,912,971
Geometric Mean 24,992,711
Coefficient Of Variation 53.15
Mean Deviation 13,028,294
Median 22,896,000
Standard Deviation 15,367,255
Range 47,678,647
R Value 0.92
R Squared 0.84
Significance 0.00002769
Slope 3,906,378

ResMed Share Based Compensation Over Time

2014  22,896,000 
2015  46,408,000 
2018  54,597,647 

Other Fundumenentals of ResMed

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

ResMed Fundamental Drivers

ResMed Fundamental Market Drivers

Short Percent Of Float1.96%
Forward Price Earnings27.20
Shares Short Prior Month2.92M
Average Daily Volume Last 10 Day1.07M
Average Daily Volume In Three Month759.28k
Date Short InterestNovember 15, 2018
Fifty Day Average105.01
Two Hundred Day Average107.30

ResMed Upcoming Events

ResMed Upcoming Company Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 27, 2017
Additionally take a look at analysis of ResMed Correlation with competitors. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Search macroaxis.com